发明名称 |
Use of CB1 antagonists and/or inverse agonists for the preparation of drugs that increase motor neuron excitability |
摘要 |
Use of a CB1 receptor antagonist and/or inverse agonist, preferably rimonabant, for the preparation of drugs useful for increasing motor neuron excitability in the cerebral cortex and/or in the brain stem and/or at the spinal level, as well as a method for increasing motor neuron excitability through the administration of a CB1 antagonist/ inverse agonist receptors, and to the use of a pharmaceutical composition which comprises a CB1 receptor antagonist and/or inverse agonist, preferably rimonabant, for increasing motor neuron excitability in the cerebral cortex and/or in the brain stem and/or at the spinal level. |
申请公布号 |
US9592237(B2) |
申请公布日期 |
2017.03.14 |
申请号 |
US201514978088 |
申请日期 |
2015.12.22 |
申请人 |
Fundacion Del Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion (FUHNPAIIN) |
发明人 |
Oliviero Antonio;de Los Reyes Aguilar Lepe Juan;Rotondi Mario;Molina Holgado Eduardo;Chiovato Luca;Foffani Guglielmo;Mordillo Mateos Laura;Lozano Sicilia Angel;Garcia Ovejero Daniel;Arevalo Martin Angel;Perez Borrego Yolanda |
分类号 |
A61K31/5377;A61P43/00;A61P25/14;A61P25/28;A61K31/454;A61P25/00;A61K31/00;A61K31/415;A61K31/4164 |
主分类号 |
A61K31/5377 |
代理机构 |
Buchanan Ingersoll & Rooney PC |
代理人 |
Buchanan Ingersoll & Rooney PC |
主权项 |
1. A method for the treatment of fatigue associated with spinal cord lesions or with Parkinson's disease, comprising administering to a patient in need thereof an effective amount of a CB1 receptor antagonist, characterized in that the CB1 receptor antagonist and/or inverse agonist is selected from the group consisting of rimonabant, a compound of the following formula: and any of their pharmaceutically acceptable salts and/or inverse agonist. |
地址 |
Toledo ES |